Dr. Neil Moat, MBBS, chief medical officer of Abbott's structural heart business, explains the latest advances in Abbott ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 20, 2021
Feature | Structural Heart Occluders | By Dave Fornell, Editor
September 20, 2021 — Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Portico ...
September 20, 2021
September 20, 2021 — The American Heart Association (AHA) announced Sept. 16 it decided to convert from a planned in ...
September 20, 2021Sponsored Content
Blog | Contrast Media Injectors
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 22, 2023
Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team ...
September 15, 2021
In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...
September 14, 2021
September 13, 2021 — The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery ...
September 13, 2021Sponsored Content
Blog | Enterprise Imaging
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 10, 2023
September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment ...
September 13, 2021
September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce ...
September 08, 2021
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke i ...
September 07, 2021Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT) ...
September 01, 2021
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart ...
September 01, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) ...
August 31, 2021Sponsored Content
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
April 11, 2023
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage ...
August 16, 2021
August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...
August 09, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence ...
August 05, 2021